BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37980692)

  • 21. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
    Milano AF
    J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
    [No Abstract]   [Full Text] [Related]  

  • 22. Malignant central nervous system tumors among adolescents and young adults (15-39 years old) in 14 Southern-Eastern European registries and the US Surveillance, Epidemiology, and End Results program: Mortality and survival patterns.
    Georgakis MK; Papathoma P; Ryzhov A; Zivkovic-Perisic S; Eser S; Taraszkiewicz Ł; Sekerija M; Žagar T; Antunes L; Zborovskaya A; Bastos J; Florea M; Coza D; Demetriou A; Agius D; Strahinja RM; Themistocleous M; Tolia M; Tzanis S; Alexiou GA; Papanikolaou PG; Nomikos P; Kantzanou M; Dessypris N; Pourtsidis A; Petridou ET
    Cancer; 2017 Nov; 123(22):4458-4471. PubMed ID: 28708937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence patterns for ependymoma: a surveillance, epidemiology, and end results study.
    McGuire CS; Sainani KL; Fisher PG
    J Neurosurg; 2009 Apr; 110(4):725-9. PubMed ID: 19061350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pilot test for linking population-based cancer registries with CCG/POG pediatric registries.
    Ross F
    J Ky Med Assoc; 2002 May; 100(5):195-9. PubMed ID: 12040910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of National Program of Cancer Registries SAS Tool for Population-Based Cancer Relative Survival Analysis.
    Dong X; Zhang K; Ren Y; Wilson R; O'Neil ME
    J Registry Manag; 2016; 43(2):63-73. PubMed ID: 27556840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
    Milano AF
    J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health disparities and impact on outcomes in children with primary central nervous system solid tumors.
    Austin MT; Hamilton E; Zebda D; Nguyen H; Eberth JM; Chang Y; Elting LS; Sandberg DI
    J Neurosurg Pediatr; 2016 Nov; 18(5):585-593. PubMed ID: 27540957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pediatric neurological cancer incidence and trends in the United States, 2000-2018.
    Kong Y; Ji X; Han X; Zhang B
    Cancer Causes Control; 2022 May; 33(5):687-699. PubMed ID: 35192107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Years of potential life lost for brain and CNS tumors relative to other cancers in adults in the United States, 2010.
    Rouse C; Gittleman H; Ostrom QT; Kruchko C; Barnholtz-Sloan JS
    Neuro Oncol; 2016 Jan; 18(1):70-7. PubMed ID: 26459813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain, other central nervous system, and eye cancer.
    Polednak AP; Flannery JT
    Cancer; 1995 Jan; 75(1 Suppl):330-7. PubMed ID: 8001004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of survival between the UK and US after surgery for most common pediatric CNS tumors.
    Mathew RK; O'Kane R; Parslow R; Stiller C; Kenny T; Picton S; Chumas PD
    Neuro Oncol; 2014 Aug; 16(8):1137-45. PubMed ID: 24799454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mortality trends in primary malignant brain and central nervous system tumors vary by histopathology, age, race, and sex.
    Thierheimer M; Cioffi G; Waite KA; Kruchko C; Ostrom QT; Barnholtz-Sloan JS
    J Neurooncol; 2023 Mar; 162(1):167-177. PubMed ID: 36928698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative survival after diagnosis with a primary brain or other central nervous system tumor in the National Program of Cancer Registries, 2004 to 2014.
    Ostrom QT; Truitt G; Gittleman H; Brat DJ; Kruchko C; Wilson R; Barnholtz-Sloan JS
    Neurooncol Pract; 2020 Jun; 7(3):306-312. PubMed ID: 32537180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and survival trends for medulloblastomas in the United States from 2001 to 2013.
    Khanna V; Achey RL; Ostrom QT; Block-Beach H; Kruchko C; Barnholtz-Sloan JS; de Blank PM
    J Neurooncol; 2017 Dec; 135(3):433-441. PubMed ID: 28828582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Descriptive epidemiology of ependymal tumours in the United States.
    Villano JL; Parker CK; Dolecek TA
    Br J Cancer; 2013 Jun; 108(11):2367-71. PubMed ID: 23660944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in central nervous system tumor incidence relative to other common cancers in adults, adolescents, and children in the United States, 2000 to 2010.
    Gittleman HR; Ostrom QT; Rouse CD; Dowling JA; de Blank PM; Kruchko CA; Elder JB; Rosenfeld SS; Selman WR; Sloan AE; Barnholtz-Sloan JS
    Cancer; 2015 Jan; 121(1):102-12. PubMed ID: 25155924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Annual report to the nation on the status of cancer, part I: National cancer statistics.
    Henley SJ; Ward EM; Scott S; Ma J; Anderson RN; Firth AU; Thomas CC; Islami F; Weir HK; Lewis DR; Sherman RL; Wu M; Benard VB; Richardson LC; Jemal A; Cronin K; Kohler BA
    Cancer; 2020 May; 126(10):2225-2249. PubMed ID: 32162336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994.
    Surawicz TS; McCarthy BJ; Kupelian V; Jukich PJ; Bruner JM; Davis FG
    Neuro Oncol; 1999 Jan; 1(1):14-25. PubMed ID: 11554386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
    Milano AF
    J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.